Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Deloitte
US Army
Teva
Colorcon
Baxter
Express Scripts
Moodys
Boehringer Ingelheim
Cerilliant

Generated: February 22, 2018

DrugPatentWatch Database Preview

Levocarnitine - Generic Drug Details

« Back to Dashboard

What are the generic sources for levocarnitine and what is the scope of levocarnitine patent protection?

Levocarnitine
is the generic ingredient in three branded drugs marketed by Leadiant Biosci Inc, Luitpold, Teva Pharms Usa, West-ward Pharms Int, Hi Tech Pharma, Lyne, and Rising Pharms Inc, and is included in nine NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Levocarnitine has four patent family members in four countries.

There are four drug master file entries for levocarnitine. Four suppliers are listed for this compound.
Pharmacology for levocarnitine
Ingredient-typeCarnitine
Drug ClassCarnitine Analog

US Patents and Regulatory Information for levocarnitine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Luitpold LEVOCARNITINE levocarnitine INJECTABLE;INJECTION 075861-001 Jun 22, 2001 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Leadiant Biosci Inc CARNITOR levocarnitine SOLUTION;ORAL 019257-001 Apr 10, 1986 AA RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int LEVOCARNITINE levocarnitine INJECTABLE;INJECTION 075567-001 Mar 29, 2001 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Rising Pharms Inc LEVOCARNITINE levocarnitine TABLET;ORAL 076858-001 Sep 20, 2004 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Leadiant Biosci Inc CARNITOR levocarnitine SOLUTION;ORAL 018948-002 Apr 27, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Leadiant Biosci Inc CARNITOR levocarnitine INJECTABLE;INJECTION 020182-001 Dec 16, 1992 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Leadiant Biosci Inc CARNITOR SF levocarnitine SOLUTION;ORAL 019257-002 Mar 28, 2007 AA RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa LEVOCARNITINE levocarnitine INJECTABLE;INJECTION 075881-001 Mar 29, 2001 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lyne LEVOCARNITINE levocarnitine SOLUTION;ORAL 076851-001 Aug 10, 2004 AA RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for levocarnitine

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,914,076 Treating chronic uremic patients undergoing periodical dialysis ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Healthtrust
Argus Health
Express Scripts
Johnson and Johnson
Merck
Colorcon
McKinsey
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot